Radcliffe Capital Management’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
SIA
ETH
AA
RCM
Radcliffe Capital Management's FSNB.WS Position: Q1 2023 in Review
Radcliffe Capital Management sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q1 2023, closing a stake of 335,932 shares — an estimated $3.37M sold.
Radcliffe Capital Management first reported a position in FSNB.WS in Q2 2021 and held it in 7 quarters. The position peaked at $3.37M in Q4 2022. 5 funds tracked by Wall St. Rank hold FSNB.WS as of Q1 2023.
- Radcliffe Capital Management reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
- Radcliffe Capital Management sold 335,932 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q1 2023, an estimated $3.37M.
- Radcliffe Capital Management first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
- Radcliffe Capital Management's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $3.37M in Q4 2022.
- 5 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q1 2023.
Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.